- Home
- CAPT vs QNCX Comparison
CAPT vs QNCX Comparison
Compare CAPT & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPT
- QNCX
- Stock Information
- Founded
- CAPT 2005
- QNCX 2012
- Country
- CAPT South Korea
- QNCX United States
- Employees
- CAPT N/A
- QNCX N/A
- Industry
- CAPT Blank Checks
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CAPT Finance
- QNCX Health Care
- Exchange
- CAPT Nasdaq
- QNCX Nasdaq
- Market Cap
- CAPT 41.9M
- QNCX 34.4M
- IPO Year
- CAPT N/A
- QNCX 2019
- Fundamental
- Price
- CAPT $0.88
- QNCX $1.78
- Analyst Decision
- CAPT
- QNCX Strong Buy
- Analyst Count
- CAPT 0
- QNCX 3
- Target Price
- CAPT N/A
- QNCX $9.67
- AVG Volume (30 Days)
- CAPT 145.7K
- QNCX 1.4M
- Earning Date
- CAPT 01-01-0001
- QNCX 11-13-2024
- Dividend Yield
- CAPT N/A
- QNCX N/A
- EPS Growth
- CAPT N/A
- QNCX N/A
- EPS
- CAPT N/A
- QNCX N/A
- Revenue
- CAPT $17,389,944.00
- QNCX N/A
- Revenue This Year
- CAPT N/A
- QNCX N/A
- Revenue Next Year
- CAPT N/A
- QNCX N/A
- P/E Ratio
- CAPT N/A
- QNCX N/A
- Revenue Growth
- CAPT 84.70
- QNCX N/A
- 52 Week Low
- CAPT $0.76
- QNCX $0.51
- 52 Week High
- CAPT $7.92
- QNCX $2.14
- Technical
- Relative Strength Index (RSI)
- CAPT 21.22
- QNCX 67.44
- Support Level
- CAPT $0.76
- QNCX $1.56
- Resistance Level
- CAPT $1.42
- QNCX $1.76
- Average True Range (ATR)
- CAPT 0.14
- QNCX 0.26
- MACD
- CAPT -0.04
- QNCX 0.03
- Stochastic Oscillator
- CAPT 14.19
- QNCX 67.54
About CAPT Captivision Inc.
Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.